Jianshu Wei

2.0k total citations
33 papers, 1.5k citations indexed

About

Jianshu Wei is a scholar working on Oncology, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Jianshu Wei has authored 33 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Biomedical Engineering and 7 papers in Molecular Biology. Recurrent topics in Jianshu Wei's work include CAR-T cell therapy research (13 papers), Nanowire Synthesis and Applications (6 papers) and Advancements in Semiconductor Devices and Circuit Design (4 papers). Jianshu Wei is often cited by papers focused on CAR-T cell therapy research (13 papers), Nanowire Synthesis and Applications (6 papers) and Advancements in Semiconductor Devices and Circuit Design (4 papers). Jianshu Wei collaborates with scholars based in China, United States and Australia. Jianshu Wei's co-authors include Weidong Han, Han Xiao, Yao Wang, Jian Bo, Zhiqiang Wu, Zhiyi Chen, Zhifeng Xiao, Chuan Tong, Yelei Guo and Bing Chen and has published in prestigious journals such as Nature Communications, Biomaterials and Scientific Reports.

In The Last Decade

Jianshu Wei

32 papers receiving 1.5k citations

Peers

Jianshu Wei
James Su United States
Farhan Chowdhury United States
Jennifer L. Leight United States
James Su United States
Jianshu Wei
Citations per year, relative to Jianshu Wei Jianshu Wei (= 1×) peers James Su

Countries citing papers authored by Jianshu Wei

Since Specialization
Citations

This map shows the geographic impact of Jianshu Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianshu Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianshu Wei more than expected).

Fields of papers citing papers by Jianshu Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianshu Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianshu Wei. The network helps show where Jianshu Wei may publish in the future.

Co-authorship network of co-authors of Jianshu Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Jianshu Wei. A scholar is included among the top collaborators of Jianshu Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianshu Wei. Jianshu Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Lu, Zhiqiang Wu, Yao Wang, et al.. (2025). CD2 augmentation enhances CAR-T-cell efficacy via immunological synapse remodeling and T-cell exhaustion mitigation. Cellular and Molecular Immunology. 22(8). 935–948. 1 indexed citations
2.
Cao, Xingyan, et al.. (2023). Multi-factor influencing on detonation quenching performance of hydrogen crimped-ribbon flame arrester. Journal of Loss Prevention in the Process Industries. 87. 105236–105236. 7 indexed citations
3.
Wang, Yao, Chuan Tong, Yuting Lu, et al.. (2023). Characteristics of premanufacture CD8+ T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma. Signal Transduction and Targeted Therapy. 8(1). 409–409. 35 indexed citations
4.
Liu, Chunyuan, Shan Liu, Yifei Hao, et al.. (2023). Field testing of blast responses and strengthening methods of reinforced autoclaved aerated concrete panels. Engineering Structures. 290. 116377–116377. 5 indexed citations
5.
Chen, Deyun, Yao Wang, Yelei Guo, et al.. (2022). Identification of NOXA as a pivotal regulator of resistance to CAR T-cell therapy in B-cell malignancies. Signal Transduction and Targeted Therapy. 7(1). 98–98. 38 indexed citations
6.
Ti, Dongdong, et al.. (2022). Inducing immunogenic cell death in immuno-oncological therapies. Chinese Journal of Cancer Research. 34(1). 1–10. 24 indexed citations
7.
Wang, Yao, Chuan Tong, Hanren Dai, et al.. (2021). Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming. Nature Communications. 12(1). 409–409. 160 indexed citations
8.
Ti, Dongdong, Xiaolei Li, Jianshu Wei, et al.. (2020). Adaptive T cell immunotherapy in cancer. Science China Life Sciences. 64(3). 363–371. 14 indexed citations
9.
Wei, Jianshu, Yelei Guo, Yao Wang, et al.. (2020). Clinical development of CAR T cell therapy in China: 2020 update. Cellular and Molecular Immunology. 18(4). 792–804. 69 indexed citations
10.
Wei, Jianshu, Han Xiao, Jian Bo, & Weidong Han. (2019). Target selection for CAR-T therapy. Journal of Hematology & Oncology. 12(1). 62–62. 150 indexed citations
11.
Wei, Jianshu, Can Luo, Yao Wang, et al.. (2019). PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activity. Journal for ImmunoTherapy of Cancer. 7(1). 209–209. 75 indexed citations
12.
Xiao, Han, Yao Wang, Jianshu Wei, & Weidong Han. (2019). Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy. Journal of Hematology & Oncology. 12(1). 128–128. 152 indexed citations
13.
Fang, Yongxiang, Bin Wang, Yannan Zhao, et al.. (2017). Collagen scaffold microenvironments modulate cell lineage commitment for differentiation of bone marrow cells into regulatory dendritic cells. Scientific Reports. 7(1). 42049–42049. 12 indexed citations
14.
Wei, Jianshu & Weidong Han. (2017). CART trials are going ahead. Science China Life Sciences. 60(11). 1276–1279. 3 indexed citations
15.
Cui, Yi, Jin Han, Zhifeng Xiao, et al.. (2016). The miR-20-Rest-Wnt signaling axis regulates neural progenitor cell differentiation. Scientific Reports. 6(1). 23300–23300. 23 indexed citations
16.
Luo, Can, Jianshu Wei, & Weidong Han. (2016). Spotlight on chimeric antigen receptor engineered T cell research and clinical trials in China. Science China Life Sciences. 59(4). 349–359. 9 indexed citations
17.
Griffon, Dominique J., et al.. (2016). Effects of Hypoxia and Chitosan on Equine Umbilical Cord‐Derived Mesenchymal Stem Cells. Stem Cells International. 2016(1). 2987140–2987140. 11 indexed citations
18.
Wei, Jianshu, Jin Han, Yannan Zhao, et al.. (2014). The importance of three-dimensional scaffold structure on stemness maintenance of mouse embryonic stem cells. Biomaterials. 35(27). 7724–7733. 58 indexed citations
19.
Cui, Yi, Zhifeng Xiao, Tong Chen, et al.. (2013). The miR-7 Identified from Collagen Biomaterial-Based Three-Dimensional Cultured Cells Regulates Neural Stem Cell Differentiation. Stem Cells and Development. 23(4). 393–405. 30 indexed citations
20.
Su, Guannan, Yannan Zhao, Jianshu Wei, et al.. (2013). Direct conversion of fibroblasts into neural progenitor-like cells by forced growth into 3D spheres on low attachment surfaces. Biomaterials. 34(24). 5897–5906. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026